BlackRock, Inc. Reduces Stake in AVITA Medical, Inc.

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing a reduction in its stake in AVITA Medical, Inc. As of September 30, 2025, BlackRock owns 1,138,436 shares, representing 4.3% of the outstanding common stock. This marks a significant decrease from its previous holdings, with a reduction of 7,493,335 shares and a value decrease of $8,700,968,868.60. The filing indicates that BlackRock's ownership is now below the 5% threshold, and the shares were acquired and are held in the ordinary course of business, not for the purpose of influencing control of the issuer. The filing was signed by Spencer Fleming, Managing Director, on October 17, 2025.